Publications for March 2018

Apps for immunization – Leveraging mobile devices to place the individual at the centre of care

K Wilson, KM Atkinson and J Westeinde

Human Vaccines & Immunotherapeutics , 2015, 11(10):2395-9

Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012

JA Bettinger, I Rouleau, MC Gariépy, WR Bowie, L Valiquette, OG Vanderkooi, JD Kellner, BL Coleman, SA McNeil, A McCarthy, G De Serres and on behalf of the Public Health Agency of Canada/Canadian Institutes for Health Research Influenza Research Network

Euro Surveill , 2015;20(29):pii=21189.

Parents and adolescents’ willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay Lac-St-Jean (Quebec)

E Dubé, D Gagnon, D Hamel, S Belley, H Gagné, N Boulianne, M Landry and J Bettinger

Can J Infect Dis Med Microbiol , 2015;26(3):163-167

Meningococcal B vaccine acceptability: Results of a longitudinal study in Quebec (Canada)

E Dubé, D Gagnon, M Quakki, B Belley, H Gagné, N Boulianne, M Landry and JA Bettinger

Vaccine Reports , 2016;6:29-35

An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination

K Wilson, K Atkinson, J Westeinde, K Bell, K Marty, D Fergusson, S Deeks, N Crowcroft and J Bettinger

Human Vaccines & Immunotherapeutics , 2016;12:1738-1748

Assessing the risk of intussusception and rotavirus vaccine safety in Canada

Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, Crowcroft NS, Halperin SA, Desai S, Naus M, Sanford CJ, Mahmud SM and Deeks SL

Hum Vaccin Immunother , 2017;13(3):703-710

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial

ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, Alimonti J, Rudge TL, Sabourin C, Silvera P, Hooper JW, Kwilas SA, Kilgore N, Badorrek C, Ramsey WJ, Heppner DG, Kemp T, Monath TP, Nowak T, McNeil SA, Langley JM, Halperin SA and Canadian Immunization Research Network

CMAJ , 2017; 189(24):E819-E827

Immunizing Patients With Adverse Events After Immunization and Potential Contraindications to Immunization: A Report From the Special Immunization Clinics Network

KA Top, M-N Billard, M-C Gariepy, I Rouleau, JM Pernica, A Pham-Huy, C Quach, D Tran, W Vaudry, S Dobson, FD Boucher, A Carignan, T Jadavji, A McConnell, SA McNeil, SA Halperin, G De Serres and Canadian Immunization Research Network’s (CIRN) Special Immunization Clinics Network investigators

CMAJ , 2016;35(12):e384-e391

Immunization practices in acute lymphocytic leukemia and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology/Oncology centers

KA Top, A Pham-Huy, V Price, L Sung, D Tran, W Vaudry, SA Halperin, G De Serres and Canadian Immunization Research Network’s (CIRN) Special Immunization Clinics Network investigators

Hum Vaccin Immunother , 2016 Apr; 12(4): 931–936.

Canadian paediatricians’ approaches to managing patients with adverse events following immunization: The role of the Special Immunization Clinic network

KA Top, J Zafack, G De Serres and SA Halperin

Paediatr Child Health , 2014;19(6):310-314.